Variables | Overall survival | |||
---|---|---|---|---|
Univariate analyses | p | Multivariate analyses | p | |
Hazara ratios | Hazara ratios | |||
(95%CI) | (95%CI) | |||
Sex | 1.067(0.526–2.162) | 0.858 | ||
Age | 1.003(0.971–1.035) | 0.877 | ||
BMI | 0.989(0.896–1.093) | 0.833 | ||
Smoke | 0.877(0.451–1.708) | 0.700 | ||
pT stage | ||||
pT2 | Ref. | |||
pT3 | 1.850(1.070–3.197) | 0.028 | 1.382(0.736–2.167) | 0.038 |
pT4 | 2.704(1.363–5.364) | 0.004 | 1.945(0.866–3.879) | 0.019 |
NLR | 0.215(0.110–0.420) | < 0.001 | 0.206(0.090–0.472) | < 0.001 |
PLR | 1.290(0.652–2.552) | 0.464 | ||
MLR | 0.240(0.109–0.526) | < 0.001 | 0.509(0.206–1.260) | 0.144 |
Chemotherapy | 1.450(0.604–3.482) | 0.406 | ||
Adverse events | 0.400(0.187–0.855) | 0.018 | 0.268(0.118–0.610) | 0.002 |